PATENT CLAIM ANALYSIS

Application Number: 15761429
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["435", "165000"]

Abstract:
One example embodiment is a method of treating lung carcinoma in a subject in need thereof. The method includes administering to the subject a therapeutically effective amount of an arginine reducing compound and a therapeutically effective amount of an ornithine decarboxylase (ODC) inhibitor to provide a combination therapy that has a synergistic therapeutic effect compared to an effect of the arginine reducing compound and an effect of the ODC inhibitor, in which each of the arginine reducing compound and the ODC inhibitor is administered alone.

Claim (Index 22):
The method of  claim 18 , wherein the arginine depleting compound and the ODC inhibitor are administered simultaneously.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 90.0
- Lexical Diversity: 1.875
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14701825', '15186795', '13878745', '15648052', '14438999']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5880311935754576
- 35 USC 102 Novelty (BERT): 0.4972249367839736
- Combined Prediction Score: 0.5789505678963092
- Mean Citation Score: 200.356602
- Max Citation Score: 206.83434
- Similarity Product: 132.74075351854918

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test